ADMA Biologics, Inc. Expands Plasma Collection Operations Of ADMA BioCenters

RAMSEY, N.J. & NORCROSS, Ga. & MARIETTA, Ga.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB: ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced the expansion of its plasma collection operations. ADMA has entered into a new lease for a second collection center and expects to commence construction at this facility during the first half of 2014. Additionally, ADMA has expanded its footprint at its Norcross, Georgia location with additional rented space to grow the donor collection and donor screening areas. This expansion is being conducted to meet an increase in market demand for source plasma.

Help employers find you! Check out all the jobs and post your resume.